AnteoTech Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.43 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive ADO News and Ratings via Email

Sign-up to receive the latest news and ratings for AnteoTech and its competitors with MarketBeat's FREE daily newsletter.

About AnteoTech

AnteoTech Limited engages in developing, commercializing, manufacturing, and distributing products for the life sciences research, vitro diagnostics, energy, and medical device markets primarily in Australia. Its principal technology products include AnteoCoat, which is applicable to the energy sector in lithium-ion batteries; AnteoBind that is applicable to point of care, in vitro, and life science diagnostic sectors. The company also manufactures and sells COVID-19 antigen testing kits. AnteoTech Limited has collaboration agreements with Axxin for for COVID-19 anigen test. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited was incorporated in 1995 and is headquartered in Eight Mile Plains, Australia.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.05 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

AnteoTech (ASX:ADO) Frequently Asked Questions

What stocks does MarketBeat like better than AnteoTech?

Wall Street analysts have given AnteoTech a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AnteoTech wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were AnteoTech's earnings last quarter?

AnteoTech Limited (ASX:ADO) released its quarterly earnings results on Wednesday, February, 27th. The company reported $0.00 EPS for the quarter.
View AnteoTech's earnings history

Who are AnteoTech's key executives?

AnteoTech's management team includes the following people:
  • Mr. Derek Thomson, Chief Exec. Officer
  • Mr. Duncan Patrick Cornish A.C.A., ACA, CFO & Company Sec. (Age 54, Pay $116k)
  • Dr. N. Joe Maeji B.Sc., Ph.D., Founder & Chief Scientific Officer
  • Ms. Friederike Graser, Communications Mang.
  • Dr. Charlie Huang B.Sc., Ph.D., Head of Diagnostics & Life Science
  • Mr. Selahattin Guldu, Exec. VP of Commercial Banking
  • Mr. Manuel Wieser, Head of Energy

Who are some of AnteoTech's key competitors?

What other stocks do shareholders of AnteoTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AnteoTech investors own include Mesoblast (MSB) and Evolution Mining (EVN).

What is AnteoTech's stock symbol?

AnteoTech trades on the ASX under the ticker symbol "ADO."

How much money does AnteoTech make?

AnteoTech has a market capitalization of $0.00 and generates $1.96 million in revenue each year.

What is AnteoTech's official website?

The official website for AnteoTech is

How can I contact AnteoTech?

The company can be reached via phone at 61 7 3219 0085.

This page was last updated on 7/30/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.